A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Lovell and CalmiGo Partner to Provide Anxiety and PTSD Relief for VeteransHealthradar20. August 2025 What You Should Know: – Lovell Government Services and CalmiGo, a mental health platform for anxiety, PTSD, and panic attacks,…
